Cobra Venom

CRISPR technology paves the way for a new antidote for Cobra bites

By Editor's Desk
19 July 2024

Every year, hundreds of individuals are killed by cobra venom, and an estimated 100,000 more suffer severe injuries from necrosis, which is the loss of bodily tissue and cells and can result in amputation.

Toxicology

Cobra’s Neurotoxic Venom | Details – Types, Effects, and Pharmacology

By Achuth B S
15 September 2023

Elapidae is a family of poisonous snakes that includes the cobras. They are recognized for their unusual looks, deadly venom, and the capacity to lift the front portion of their bodies when attacked, generating a distinctive hood shape.

Tag: Cobra Venom

CRISPR technology paves the way for a new antidote for Cobra bites

Cobra’s Neurotoxic Venom | Details – Types, Effects, and Pharmacology

Areas Covered

Discover More

Novartis Fabhalta Iptacopan FDA Approval Becomes First Complement Inhibitor to Slow Kidney Decline in Primary IgAN

LIPFENDRA FDA Approval: Merck’s Enlicitide Becomes First Oral PCSK9 Inhibitor to Lower LDL-C

GSK Nuvalent Acquisition: GSK Completes $10.6 Billion Nuvalent Acquisition, Expanding Lung Cancer Pipeline

Johnson & Johnson Q2 2026 Analysis: Company Reports $25.3 Billion in Sales, Raises Full-Year Outlook

Merck’s Erbitux BRAF V600E mCRC Regimen Gets EU Approval for First-Line Treatment

AstraZeneca Zegfrovy Deal: AstraZeneca Licenses Dizal’s Oral EGFR Inhibitor for Lung Cancer in Up to $1.5 Billion Agreement